HUAPONT PHARM.

INFORMATION CENTER

26

2019

-

08

重庆华邦胜凯制药有限公司长寿分公司原料药生产项目 环境影响评价公众参与第二次公示

Author:


  根据《中华人民共和国环境影响评价法》及《环境影响评价公众参与办法》等相关规定,现将重庆华邦胜凯制药有限公司长寿分公司原料药生产项目环境影响评价有关信息予以第二次公示。
  (一)环境影响报告书征求意见稿全文的网络链接及查阅纸质报告书的方式和途径
  《重庆华邦胜凯制药有限公司长寿分公司原料药生产项目环境影响报告书》(征求意见稿)全文网络链接:见本次公示附件。
  查阅纸质报告书的方式和途径:重庆华邦胜凯制药有限公司
  (二)征求意见的公众范围
  拟建项目环境影响评价范围内的公民、法人和其他组织等。
  (三)公众意见表的网络链接
  公众意见表网络链接:见本次公示附件。
  (四)公众提出意见的方式和途径
  公众可以通过信函、传真、电子邮件和现场填写等方式,在规定时间内将填写的公众意见表等提交我单位,反映与建设项目环境影响有关的意见和建议。公众提交意见时,应当提供有效的联系方式。鼓励公众采用实名方式提交意见并提供常住地址。
  建设单位:重庆华邦胜凯制药有限公司长寿分公司
  地址:合川区南津街街道办事处荣军路666号
  联系人:安环部邓部长  电话023-42751758  邮箱42751758@163.com。
  (五)公众提出意见的起止时间
  2019年8月27日~2019年9月10日。
  重庆华邦胜凯制药有限公司长寿分公司
2019年8月26日
 

Latest News

2022-09-20

A new base of Huapont was officially completed and put into use

On September 19, 2022, the completion and commissioning ceremony of a new base was held, the new base is located in Changshou District, Chongqing. The construction of Changshou Base started on October 8, 2019, after 2 years and 11 months of construction, the total construction area 89036.79㎡ was completed, including four buildings for API, four buildings for storage warehouses, one building fro QC, one power center and one sewage treatment station. All plants are operated by gravity flow and equipped with automatic control systems such as DCS, SIS, BMS and WMS.

2022-05-31

Huapont Pharma was awarded the 2021 Outstanding Company for National Adverse Drug Reaction Monitoring and Evaluation

The National Adverse Drug Reaction Monitoring Center commended Huapont Pharm. Due to its outstanding for performing the main responsibility. Meanwhile, Huapont Pharm. is also the only pharmaceutical manufacturer in Chongqing that has been commended. Under the leadership of the Drug Safety Committee

2022-03-03

Huapont passed the NMPA GMP inspection for large-scale injection

From February 22 to February 25, 2022, and from March 1 to March 4, 2022, NMPA (National Medical Products Administration), Chongqing conducted on-site inspection for large-volume injection. The officers conducted a comprehensive inspection. including the R&D area and production site of the injection solution, specifically, the quality management and control at the site,

2021-12-29

Huapont Pharm. won the title of "Green Factory"

Huapont Pharm. was successfully approved as a municipal green factory recently by Chongqing Municipal Economic and Information Commission It is the recognition of the company's green development, healthy development and sustainable development. Huapont Pharm. Will always focus on the concept of green development, adhere to green manufacturing, vigorously promote our company's development towards low consumption, green and ecological, and strive to complete the creation of national green factories.

2021-12-17

Huapont was certified with <Certificate of Intellectual Property Management System>.

Our management system of intellectual property was inspected by Zhongbiaotong International Certification (Shenzhen) Co., Ltd. from December 8th to 10th. Huapont Management system of intellectual property was accredited as complying with the "GB/T 29490-2013 Enterprise Intellectual Property Management Specification". Huapont was certified with <Certificate of Intellectual Property Management System>.

2021-12-16

Huapont passed the NMPA GMP inspection for sterile preparation workshop

Chongqing Municipal Drug Administration conducted an inspection for sterile preparation workshop of Huapont on December 1st ~ 2nd in 2021. During inspection, quality related management documentations were comprehensively and deeply reviewed,